Zacks: Analysts Expect Aspen Aerogels Inc (NYSE:ASPN) Will Post Quarterly Sales of $26.10 Million

Equities research analysts expect Aspen Aerogels Inc (NYSE:ASPN) to post $26.10 million in sales for the current quarter, according to Zacks. Three analysts have made estimates for Aspen Aerogels’ earnings. The highest sales estimate is $26.60 million and the lowest is $25.70 million. Aspen Aerogels reported sales of $35.43 million in the same quarter last year, which indicates a negative year-over-year growth rate of 26.3%. The company is expected to issue its next quarterly earnings results on Thursday, October 29th.

On average, analysts expect that Aspen Aerogels will report full-year sales of $106.87 million for the current financial year, with estimates ranging from $105.10 million to $108.10 million. For the next year, analysts expect that the firm will report sales of $132.81 million, with estimates ranging from $119.90 million to $140.00 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Aspen Aerogels.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Thursday, July 30th. The construction company reported ($0.21) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by ($0.01). Aspen Aerogels had a negative return on equity of 19.00% and a negative net margin of 8.97%. The business had revenue of $24.64 million for the quarter, compared to analysts’ expectations of $22.60 million.

A number of equities analysts have recently issued reports on ASPN shares. Canaccord Genuity reiterated a “buy” rating and issued a $10.00 price objective on shares of Aspen Aerogels in a report on Friday, July 31st. HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares of Aspen Aerogels in a report on Friday, July 31st. Zacks Investment Research cut Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Wednesday, August 5th. Finally, Northland Securities initiated coverage on Aspen Aerogels in a report on Wednesday, September 9th. They issued an “outperform” rating and a $11.00 price objective for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company’s stock. Aspen Aerogels currently has an average rating of “Buy” and a consensus target price of $10.18.

Shares of ASPN traded up $0.62 during midday trading on Monday, reaching $11.57. The stock had a trading volume of 3,734,461 shares, compared to its average volume of 151,841. The company’s 50-day moving average is $9.08 and its 200 day moving average is $6.98. Aspen Aerogels has a 12-month low of $4.09 and a 12-month high of $14.63. The company has a current ratio of 3.26, a quick ratio of 2.55 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $310.60 million, a price-to-earnings ratio of -23.30 and a beta of 1.86.

A number of hedge funds have recently modified their holdings of ASPN. Driehaus Capital Management LLC bought a new position in Aspen Aerogels during the 1st quarter valued at approximately $2,616,000. Parametric Portfolio Associates LLC bought a new position in Aspen Aerogels during the 1st quarter valued at approximately $1,461,000. Needham Investment Management LLC raised its position in Aspen Aerogels by 24.9% during the 1st quarter. Needham Investment Management LLC now owns 1,130,000 shares of the construction company’s stock valued at $6,938,000 after purchasing an additional 225,350 shares during the last quarter. Baird Financial Group Inc. bought a new position in Aspen Aerogels during the 1st quarter valued at approximately $751,000. Finally, Oaktop Capital Management II L.P. raised its position in Aspen Aerogels by 3.5% during the 2nd quarter. Oaktop Capital Management II L.P. now owns 2,939,758 shares of the construction company’s stock valued at $19,344,000 after purchasing an additional 100,000 shares during the last quarter. Institutional investors own 71.23% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, an aerogel technology company, designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets worldwide. The company provides Pyrogel XT-E that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market with operating temperatures greater than 400 C; Pyrogel XTF to provide strong protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.

See Also: The benefits and drawbacks of dollar cost averaging

Get a free copy of the Zacks research report on Aspen Aerogels (ASPN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.